adenocarcinoma of the prostate
Showing 26 - 50 of 8,290
Prostate Cancer, Prostate Adenocarcinoma, Prostate Tumor Trial (other, radiation, procedure)
Not yet recruiting
- Prostate Cancer
- +2 more
- Risk Map Decision Support System (DSS).
- +2 more
- (no location specified)
Jan 25, 2023
Prostate Disease, Malignancy, Benign Prostatic Hyperplasia Trial in Boston (Self-Administered Nitrous Oxide, Oxygen)
Completed
- Prostate Disease
- +6 more
- Self-Administered Nitrous Oxide
- Oxygen
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Mar 25, 2023
Prostate Cancer, Prostate Adenocarcinoma Trial in Columbia (Ga-68-PSMA-11)
Terminated
- Prostate Cancer
- Prostate Adenocarcinoma
-
Columbia, MissouriTruman VA Hospital
Feb 15, 2023
Prostate Cancer, Prostate Adenocarcinoma Trial in Tampa (Sunphenon, Placebo)
Recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Sunphenon
- Placebo
-
Tampa, Florida
- +1 more
Dec 19, 2022
Prostate Cancer, Prostate Cancer Metastatic, Prostate Adenocarcinoma Trial (Relugolix Pill, Ritonavir, Itraconazole)
Not yet recruiting
- Prostate Cancer
- +2 more
- Relugolix Pill
- +2 more
- (no location specified)
Dec 23, 2022
Prediction of Lymph Node Invasion for Prostate Adenocarcinoma
Recruiting
- Adenocarcinoma of the Prostate
-
Brest, FranceCHRU Brest
Jan 17, 2022
Localized Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Best Practice, Dietary Intervention, Exercise
Recruiting
- Localized Prostate Carcinoma
- Prostate Adenocarcinoma
- Best Practice
- +4 more
-
Seattle, Washington
- +1 more
Jan 9, 2023
Prostate Cancer, Cancer of Prostate, Prostate Adenocarcinoma Trial (Stereotactic Ablative Body Radiation)
Not yet recruiting
- Prostate Cancer
- +2 more
- Stereotactic Ablative Body Radiation
- (no location specified)
Oct 26, 2022
Prostate Cancer Trial in Baltimore (hypofractionation)
Active, not recruiting
- Prostate Cancer
- hypofractionation
-
Baltimore, MarylandThe Johns Hopkins University School of Medicne
Mar 18, 2022
Prostate Cancer, Prostate Adenocarcinoma, Localized Prostate Carcinoma Trial in United States (Exercise Therapy)
Recruiting
- Prostate Cancer
- +2 more
- Exercise Therapy
-
Los Angeles, California
- +7 more
Feb 20, 2023
Prostate Cancer, Prostate Adenocarcinoma Trial in Charlotte (ADT+Docetaxel+Enzalutamide)
Active, not recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
-
Charlotte, North CarolinaLevine Cancer Institute
Jan 12, 2023
Tumor Molecular Profiling in Patients With Prostate Cancer
Completed
- Prostate Cancer
- Metastatic Prostate Adenocarcinoma
- Tumor molecular profiling
-
Athens, GreeceHellenic Cooperative Oncology Group
Oct 17, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)
Not yet recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Relacorilant
- +4 more
- (no location specified)
Feb 2, 2023
Prostate Adenocarcinoma Trial in Valence, Clermont-Ferrand, Lyon (Integrated boost)
Recruiting
- Prostate Adenocarcinoma
- Integrated boost
-
Valence, DrĂ´me, France
- +3 more
Oct 26, 2022
Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Recurrent Prostate Adenocarcinoma Trial in Los Angeles (drug,
Not yet recruiting
- Oligometastatic Prostate Carcinoma
- +3 more
- Lutetium Lu-177 PNT2002
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Aug 15, 2022
Metastatic Prostate Adenocarcinoma, Castration-resistant Prostate Cancer, Prostate Cancer Trial in Boston (Neratinib)
Terminated
- Metastatic Prostate Adenocarcinoma
- +3 more
-
Boston, Massachusetts
- +2 more
Jul 18, 2022
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Laboratory Biomarker Analysis, Olaparib,
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
- Laboratory Biomarker Analysis
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 19, 2022
Prostate Cancer Adenocarcinoma, Erectile Dysfunction Following Radical Prostatectomy Trial (using Indocyanine Green,
Not yet recruiting
- Prostate Cancer Adenocarcinoma
- Erectile Dysfunction Following Radical Prostatectomy
- using Indocyanine Green
- Nerve-sparing robot-assisted laparoscopic radical prostatectomy
- (no location specified)
Jul 21, 2023
Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (biological, drug, other)
Recruiting
- Biochemically Recurrent Prostate Carcinoma
- Prostate Adenocarcinoma
- Durvalumab
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 26, 2023
Prostate Cancer, Prostate Adenocarcinoma Trial in Moscow (consequently performed 4 biopsy methods (TRUS-guided biopsy,
Completed
- Prostate Cancer
- Prostate Adenocarcinoma
- consequently performed 4 biopsy methods (TRUS-guided biopsy, cognitive, fusion and transperineal template mapping biopsy)
-
Moscow, Russian FederationInstitute for Urology and Reproductive Health, Sechenov Universi
Oct 18, 2022
Metastatic Castration-Resistant Prostate Adenocarcinoma Trial in United States (CCW702)
Active, not recruiting
- Metastatic Castration-Resistant Prostate Adenocarcinoma
-
San Diego, California
- +4 more
Sep 29, 2022
Prostate Adenocarcinoma Trial in Haifa (Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT))
Recruiting
- Prostate Adenocarcinoma
- Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
-
Haifa, Israel
- +1 more
Jul 4, 2022
Quantitative HP MRI for Clinical Prostate Cancer Exam
Active, not recruiting
- Prostate Adenocarcinoma
- Hyperpolarized Carbon C 13 Pyruvate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2022
Prostate Cancer Trial in Philadelphia (Proton Beam Radiation Therapy, Quality-of-Life assessment, Questionnaire Administration)
Terminated
- Prostate Cancer
- Proton Beam Radiation Therapy
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jan 30, 2023